InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Discover the detailed record of transactions filed by Kimball Aaron, Officier. Officer active across 1 companies, notably Zymergen Inc.. Aggregated, 12 disclosures have been published. Total volume traded: €829k. The latest transaction was filed on 1 April 2022 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
€64,18925,000 shares@ €2.56767.1% of flow
Common Stock
SEC:0001645842-22-000052:0·
€85,00925,000 shares@ €3.40039.5% of flow
Common Stock
SEC:0001645842-22-000028:0·
€112,74225,000 shares@ €4.509712.5% of flow
Common Stock
SEC:0001645842-22-000013:0·
€112,74225,000 shares@ €4.509730.1% of flow
Common Stock
SEC:0001645842-22-000013·
€227,05350,000 shares@ €4.541160.6% of flow
Common Stock
SEC:0001645842-22-000007·
€227,05350,000 shares@ €4.541125.3% of flow
Common Stock
SEC:0001645842-22-000007:0·
05,000 shares0
Common Stock
SEC:0001645842-21-000042·
05,000 shares0
Common Stock
SEC:0001645842-21-000042:0·
085,000 shares0
Common Stock
SEC:0001645842-21-000025·
085,000 shares0
Common Stock
SEC:0001645842-21-000025:0·
€34,8159,000 shares@ €3.86839.3% of flow
Common Stock
SEC:0001645842-21-000020·
€34,8159,000 shares@ €3.86833.9% of flow
Common Stock
SEC:0001645842-21-000020:0·
12 of 12 declarations
About Kimball Aaron
Aaron Kimball is the Chief Technology Officer of Zymergen Inc. In this role, he oversees the company's technology operations. Zymergen is a biotechnology company specializing in innovation. Aaron plays a key role in developing new technologies and innovation.
